Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes management and subsequently approved by the FDA for chronic weight management
While your medical team can assist you, developing a mindset where you view yourself as someone who is actively and successfully building a healthy life also helps
Welcome to the PlexusDx Education Hub, where we translate GLP-1 therapy, weight-management protocols, and the genetics behind them into decisions you can actually use
A loss-of-function shRNA targeted screen in metastatic-derived cells identified Gstt1 , a member of the glutathione S -transferase superfamily, as uniquely required for dissemination and metastasis, but dispensable for primary tumour growth
The daily dose is 1 scoop (7 grams)
Insurance is more likely to cover GLP-1s for type 2 diabetes or cardiovascular disease than for weight loss, regardless of whether you take a pill or injection